Golden
DNALite Therapeutics

DNALite Therapeutics

DNALite Therapeutics is a biotechnology company focused on developing prevention and treatment for gastrointestinal diseases.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

August 2018

DNALite Therapeutics raises a $1,500,000 seed round from Baldota family, University of California, Berkeley, Blue Bear Ventures, BrightGene, SVE Capital, Berkeley Catalyst Fund and SOSV.

Funding rounds

People

Name
Role
LinkedIn

Mubhij Ahmad

Employee



Timothy Day

Founder



Further reading

Title
Author
Link
Type
Date
+ Add new row

Documentaries, videos and podcasts

Title
Date
Link
+ Add new row

Companies

Company
CEO
Location
Products/Services
+ Add new row